Skip to main content
. 2020 Jul 29;21(15):5404. doi: 10.3390/ijms21155404
ABMR antibody-mediated rejection
cABMR chronic antibody-mediated rejection
AI artificial intelligence
AR acute rejection
ATN acute tubular necrosis
AT1R Angiotensin 2 receptor 1
AUC area under the curve
CAD chronic allograft dysfunction
CNI calcineurin inhibitor
Col-IV Collagen type IV
CsA Cyclosporin A
DCD donation after circulatory death
DBD donation after brain death
DGF delayed graft function
DSA donor-specific antibodies
ECD extended criteria donor
EDIL-3 EGF-like repeats and discoidin I-like domains 3
EM extracellular matrix
EMT epithelial-to-mesenchymal transition
ENDATs endothelial associated transcripts
EndMT endothelial-to-mesenchymal transition
ETAR endothelin type A receptor
EVs extracellular vesicles
FLT3-L Fms-like tyrosine kinase-3 ligand
FN Fibronectin
GFR glomerular filtration rate
GST glutathione S-transferase
HLA human leukocyte antigen
HSP heat shock protein
ICAM-4 intercellular adhesion molecule 4
IFTA interstitial fibrosis tubular atrophy
iIFTA inflammatory interstitial fibrosis tubular atrophy
IRI ischemia-reperfusion injury
kSORT kidney solid organ response test
KTx kidney transplant
KTR-3 Keratin-3
FST furosemide stress test
LD living-donor
MFI mean fluorescence intensity
MMP-2 matrix metalloprotein-2
miRNA microRNA
NGAL neutrophil gelatinase-associated lipocalin
NPP negative predictive power
PBTs pathogenesis-based transcript sets
pEMT partial epithelial-to-mesenchymal transition
POSTN Periostin
PVAN Polyomavirus-associated nephropathy
PPP Positive predictive power
ROC receiver operating characteristic
SNP single nucleotide polymorphism
TAC Tacrolimus
TCMR T-cell mediated rejection
tCRM tissue common rejection module
TIMP-2 tissue inhibitor of metalloproteinases-2
TLR-4 Toll-like receptor 4
VIM Vimentin